The FDA’s new Rare Disease Framework Initiative aims to make rare disease drug reviews more consistent. A public meeting is ...

Roche will propose cancer targets and Hansoh will build antibody-drug conjugates against them, with $400 million upfront and $15B+ in milestones.

Merck & Co. remains the “big dog” in the pharma industry in 2025, with roughly $64.17 billion in FY2024 revenue. It claimed the top position a year earlier. Drawing on continued Keytruda momentum, ...

A team from ETH Zurich and Karolinska Institutet has developed a cross-linking MALDI mass spectrometry workflow that captures both functional response and target binding in a single assay. Drug ...

Eli Lilly has agreed to acquire AtaiBeckley for $2.8 billion upfront, plus up to $1 billion in contingent value rights, in a deal that could reach $3.8 billion. The acquisition would make Lilly the ...

The FDA has finalized new guidelines for meetings between the FDA and sponsors or applicants relating to the development and review of drugs or biological products under the Prescription Drug User Fee ...

Beyfortus can help prevent a serious lung disease associated with RSV in children up to 24 months old. Beyfortus is a preventative antibody administered as an injection and is “backed by more than 40 ...

The international biotech sector clocked in at $1.37 trillion in 2022 despite headwinds such as slow launches, long-term drug pricing shifts and changing consumer behavior. Recent biotech ...

At its recent annual Science Day, Moderna signalled a strategic expansion beyond its established vaccine and rare disease franchises, unveiling new programs in in vivo CAR-T and solid tumor oncology.

Earendil Labs and NewLimit round out the top three slots in the ranking below, which is limited to private biotechs that announced or disclosed financing between Jan. 1 and Aug. 12, 2026. Earendil ...

The headline fight in FY2025 pharma happened at the very top of the leaderboard, where Keytruda held the No. 1 brand slot even as Lilly’s tirzepatide and Novo’s semaglutide passed it at the molecule ...